Literature DB >> 28255902

Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.

Andrés Server1, Nuria Bargalló2,3, Yngvar Fløisand4, Jon Sponheim5, Francesc Graus6,7, John K Hald8,9.   

Abstract

Neurologic complications are common after hematopoietic stem cell transplantation (HSCT) and solid organ transplantation (SOT) and affect 30-60% of transplant recipients. The aim of this article is to provide a practical imaging approach based on the timeline and etiology of CNS abnormalities, and neurologic complications related to transplantation of specific organs. The lesions will be classified based upon the interval from HSCT procedure: pre-engraftment period <30 days, early post-engraftment period 30-100 days, late post-engraftment period >100 days, and the interval from SOT procedure: postoperative phase 1-4 weeks, early posttransplant syndromes 1-6 months, late posttransplant syndromes >6 months. Further differentiation will be based on etiology: infections, drug toxicity, metabolic derangements, cerebrovascular complications, and posttransplantation malignancies. In addition, differentiation will be based on complications specific to the type of transplantation: allogeneic and autologous hematopoietic stem cells (HSC), heart, lung, kidney, pancreas, and liver. Thus, in this article we emphasize the strategic role of neuroradiology in the diagnosis and response to treatment by utilizing a methodical approach in the work up of patients with neurologic complications after transplantation.

Entities:  

Keywords:  Brain; Hematopoietic stem cell transplantation; Magnetic resonance imaging; Neurologic complications; Solid organ transplantation

Mesh:

Year:  2017        PMID: 28255902     DOI: 10.1007/s00234-017-1804-4

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  163 in total

Review 1.  Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.

Authors:  M A Kharfan-Dabaja; E Ayala; J Greene; A Rojiani; F R Murtagh; C Anasetti
Journal:  Bone Marrow Transplant       Date:  2006-12-04       Impact factor: 5.483

2.  Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.

Authors:  M A Nalesnik; E S Woodle; J M Dimaio; B Vasudev; L W Teperman; S Covington; S Taranto; J P Gockerman; R Shapiro; V Sharma; L J Swinnen; A Yoshida; M G Ison
Journal:  Am J Transplant       Date:  2011-06       Impact factor: 8.086

3.  Acute hyperammonemic encephalopathy in adults: imaging findings.

Authors:  J M U-King-Im; E Yu; E Bartlett; R Soobrah; W Kucharczyk
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-18       Impact factor: 3.825

Review 4.  Neuroimaging of infections.

Authors:  Oliver Kastrup; Isabel Wanke; Matthias Maschke
Journal:  NeuroRx       Date:  2005-04

5.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

6.  Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.

Authors:  Deborah Siegal; Anne Keller; Wei Xu; Sandeep Bhuta; Dong Hwan Kim; John Kuruvilla; Jeffrey H Lipton; Hans Messner; Vikas Gupta
Journal:  Biol Blood Marrow Transplant       Date:  2007-09-21       Impact factor: 5.742

Review 7.  Neurologic complications of bone marrow transplantation.

Authors:  Tulio E Rodriguez
Journal:  Handb Clin Neurol       Date:  2014

8.  Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings.

Authors:  W T Yuh; H D Nguyen; F Gao; E T Tali; D J Fisher; N A Mayr; D P Mueller; Y Sato; M E Trigg; R Gingrich
Journal:  AJR Am J Roentgenol       Date:  1994-02       Impact factor: 3.959

Review 9.  Neuroimaging and neurologic complications after organ transplantation.

Authors:  Sasa Zivković
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

10.  Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

Authors:  Joshua A Hill; Sophia Koo; Belisa B Guzman Suarez; Vincent T Ho; Corey Cutler; John Koreth; Philippe Armand; Edwin P Alyea; Lindsey R Baden; Joseph H Antin; Robert J Soiffer; Francisco M Marty
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-04       Impact factor: 5.742

View more
  6 in total

Review 1.  [MRI alterations in immunomodulation].

Authors:  K Guggenberger; H Urbach
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

Review 2.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

3.  2017/2018.

Authors:  Rüdiger von Kummer
Journal:  Neuroradiology       Date:  2018-01       Impact factor: 2.804

4.  Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients.

Authors:  Ali Önder Atça; Berrin Erok; Selime Aydoğdu
Journal:  BMC Pediatr       Date:  2021-10-11       Impact factor: 2.125

Review 5.  Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Zhuo Wang; Munan Zhao; Sujun Gao
Journal:  Front Neurol       Date:  2021-07-16       Impact factor: 4.003

Review 6.  Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage.

Authors:  Iside Alessi; Anna Maria Caroleo; Luca de Palma; Angela Mastronuzzi; Stefano Pro; Giovanna Stefania Colafati; Alessandra Boni; Nicoletta Della Vecchia; Margherita Velardi; Melania Evangelisti; Alessia Carboni; Andrea Carai; Luciana Vinti; Massimiliano Valeriani; Antonino Reale; Pasquale Parisi; Umberto Raucci
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.